Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05897671
Other study ID # FSI
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 1, 2023
Est. completion date June 1, 2023

Study information

Verified date June 2023
Source Vienna Institute for Research in Ocular Surgery
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Foveal sparing internal limiting membrane (ILM) peeling with ILM flap transposition over the macular hole combines the benefits of foveal sparing ILM peeling with ILM flap techniques. Aim of this study is to retrospectively examine the rate of postsurgical macular hole closure, development of central atrophy in the foveal area, and improvement of best corrected distant visual acuity in a group of patients having undergone foveal sparing ILM peeling with ILM flap transposition for macular hole repair.


Description:

Idiopathic full thickness macular holes lead to central defects in the visual field and to deterioration of the visual acuity. Introduction of internal limiting membrane (ILM) Peeling techniques lead to significant increase in closure rates of the macular holes. Foveal sparing ILM peeling represents a surgical technique for macular hole repair with less surgical trauma with high closure rates of the macular hole, compared to classic ILM Peeling [Ho et al. 2014, Murphy et al 2019]. The combination of foveal sparing ILM Peeling with the established ILM flap techniques [Michalewska et al 2010 und 2015] offers the potential of better improvement in postsurgical visual acuity with the high closure rates, due to ILM flaps. Aim of this study is to retrospectively examine the rate of postsurgical macular hole closure, development of central atrophy in the foveal area, and improvement of best corrected distant visual acuity in a group of patients having undergone foveal sparing ILM peeling with ILM flap transposition for macular hole repair.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date June 1, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Vitrectomy with foveal sparing ILM peeling with ILM flap transposition in the time period from 1.10.2020 to 8.7.2022 - Age 18 and older - Idiopathic full thickness macular hole as indication for surgery - Full follow-up, including visual acuity testing and OCT preoperative, and 3 months after surgery. Exclusion Criteria: - Age <18 years

Study Design


Related Conditions & MeSH terms


Intervention

Other:
retrospective data analysis
Macular hole closure rate, visual acuity and OCT

Locations

Country Name City State
Austria Hanusch Hospital, Department of Ophthalmology Vienna

Sponsors (1)

Lead Sponsor Collaborator
Vienna Institute for Research in Ocular Surgery

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary macular hole closure rate postsurgical closure of macular holes is examined from routine postsurgical optical coherence tomography (OCT) imaging up to 3 months after surgery
Secondary visual acuity visual acuity before and 3 months after surgery is examined 3 months
Secondary OCT measurements of macular hole diameters from presurgical OCTs and restoration of the ellipsoid zone (EZ) 3 months after surgery is analysed 3 months
See also
  Status Clinical Trial Phase
Completed NCT03332758 - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Completed NCT01020760 - Protocol for RCT of Posturing in Phacovitrectomy for Full Thickness Macular Hole (FTMH) N/A
Recruiting NCT04498624 - Inverted Flap Versus Internal Limiting Membrane Peeling in Small Full Thickness Macular Holes N/A
Completed NCT01226160 - Pilot Randomised Controlled Trial of Posturing Following Surgery for Full-thickness Macular Hole Phase 0
Recruiting NCT05828251 - Full Thickness Macular Hole; Should it be Handled Subacutely? N/A